Alliance for Pandemic Preparedness
April 3, 2020
Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia.
Category: Article Summary
Topic: Testing and Treatment
- Pizzorno et al provide new insights on SARS-CoV-2 biology, evidence on the antiviral efficacy of remdesivir, and the therapeutic potential of a virus-detected and a host-direct drug combination (e.g. remdesivir-diltiazem combination) as a probable option to respond to the current unmet medical need imposed by COVID-19.
Pizzorno et al. (Mar 31, 2020). Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Pre-print downloaded Apr 3 from https://doi.org/10.1101/2020.03.31.017889